Eléments de l'association
|
List of bibliographic references
Number of relevant bibliographic references: 22.Ident. | Authors (with country if any) | Title |
---|---|---|
002296 | Pershia Samadi [Canada] ; Marc Morissette [Canada] ; Fréderic Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Mehdi Dridi [Canada] ; Nancy Belanger [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Normalization of GABAA receptor specific binding in the substantia nigra reticulata and the prevention of L‐dopa‐induced dyskinesias in MPTP parkinsonian monkeys |
002725 | Pershia Samadi [Canada] ; Paul J. Bédard ; Claude Rouillard | Opioids and motor complications in Parkinson's disease. |
002805 | Marc Morissette [Canada] ; Mehdi Dridi [Canada] ; Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Prevention of levodopa‐induced dyskinesias by a selective NR1A/2B N‐methyl‐D‐aspartate receptor antagonist in parkinsonian monkeys: Implication of preproenkephalin |
002806 | Marc Morissette [Canada] ; Mehdi Dridi [Canada] ; Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: Effect on adenosine A2A receptors |
002851 | Pershia Samadi [Canada] ; Laurent Grégoire [Canada] ; Claude Rouillard [Canada] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] ; Daniel Lévesque [Canada] | Docosahexaenoic acid reduces levodopa‐induced dyskinesias in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine monkeys |
002B88 | Abdallah Hadj Tahar [Canada] ; Laurent Grégoire ; Aurélie Darré ; Nancy Bélanger ; Leonard Meltzer ; Paul J. Bédard | Effect of a selective glutamate antagonist on L-dopa-induced dyskinesias in drug-naive parkinsonian monkeys. |
002D75 | Frédéric Calon [Canada] ; Ali H. Rajput ; Oleh Hornykiewicz ; Paul J. Bédard ; Thérèse Di Paolo | Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease. |
003237 | Frédéric Calon [Canada] ; Nadia Lavertu [Canada] ; Anne-Marie Lemieux [Canada] ; Marc Morissette [Canada] ; Martin Goulet [Canada] ; Richard Grondin [Canada] ; Pierre J. Blanchet [Canada] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Effect of MPTP‐induced denervation on basal ganglia GABAB receptors: Correlation with dopamine concentrations and dopamine transporter |
003512 | Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Pierre J. Blanchet [Canada] ; Marc Morissette [Canada] ; Richard Grondin [Canada] ; Martin Goulet [Canada] ; Jean-Pierre Doucet [Canada] ; George S. Robertson [Canada] ; Eric Nestler [États-Unis] ; Thérèse Di Paolo [Canada] ; Paul J. Bédard [Canada] | Dopamine-receptor stimulation: biobehavioral and biochemical consequences |
003672 | Richard Grondin [Canada] ; Martin Goulet [Canada] ; Marc Morissette [Canada] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Dopamine D1 receptor mRNA and receptor levels in the striatum of MPTP monkeys chronically treated with SKF-82958 |
003681 | Frédéric Calon ; Marc Morissette ; Martin Goulet ; Richard Grondin ; Pierre J. Blanchet ; Paul J. Bédard ; Thérèse Di Paolo [Canada] | Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys: effects on basal ganglia GABAA/benzodiazepine receptor complex and GABA content |
003890 | Julien Doyon [Canada] ; Robert Laforce Jr. [Canada] ; Ginette Bouchard [Canada] ; Danielle Gaudreau [Canada] ; Joanne Roy [Canada] ; Marie Poirier [Canada] ; Paul J. Bédard [Canada] ; Fernand Bédard [Canada] ; Jean-Pierre Bouchard [Canada] | Role of the striatum, cerebellum and frontal lobes in the automatization of a repeated visuomotor sequence of movements |
003A98 | Marc Morissette [Canada] ; Martin Goulet [Canada] ; Jean-Jacques Soghomonian [Canada] ; Pierre J. Blanchet [Canada] ; Frédéric Calon [Canada] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with l-DOPA therapy |
003D21 | Jean-Jacques Soghomonian [Canada] ; Sophie Pedneault [Canada] ; Pierre J. Blanchet [Canada] ; Martin Goulet [Canada] ; Thérèse Di Paolo [Canada] ; Paul J. Bédard [Canada] | l-DOPA regulates glutamate decarboxylases mRNA levels in MPTP-treated monkeys |
003D48 | Paul J. Bédard [Canada] | Motor activity & movement disorders. Research issues and applications |
003D77 | Pierre J. Blanchet [Canada] ; Richard Grondin [Canada] ; Paul J. Bédard [Canada] ; Kazumi Shiosaki [États-Unis] ; Donald R. Britton [États-Unis] | Dopamine D1 receptor desensitization profile in MPTP-lesioned primates |
003F76 | Céline Gagnon [Canada] ; Baltazar Gomez-Mancilla [Canada] ; Rudolf Markstein [Suisse] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Effect of adding the D-1 agonist CY 208–243 to chronic bromocriptine treatment of MPTP-monkeys: Regional changes of brain dopamine receptors |
004526 | Baltazar Gomez-Mancilla [Canada] ; Paul J. Bédard [Canada] | Effect of chronic treatment with (+)-PHNO, a D2 agonist in MPTP-treated monkeys |
004899 | Céline Gagnon [Canada] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Effect of chronic treatment of MPTP monkeys with dopamine D-1 and/or D-2 receptor agonists |
004A66 | Paul J. Bédard [Canada] ; René Boucher [Canada] | Effect of D1 receptor stimulation in normal and MPTP monkeys |
004C41 | Michel Filion [Canada] ; Léon Tremblay [Canada] ; Paul J. Bédard [Canada] | Abnormal influences of passive limb movement on the activity of globus pallidus neurons in parkinsonian monkeys |
004D68 | Jean-Claude Martel [Canada] ; Serge St-Pierre [Canada] ; Paul J. Bédard [Canada] ; Rémi Quirion [Canada] | Comparison of [125I]Bolton-Hunter neuropeptide Y binding sites in the forebrain of various mammalian species |
This area was generated with Dilib version V0.6.29. |